Related Experiment Videos
Clinical trials in head injury
Raj K Narayan1, Mary Ellen Michel, Beth Ansell
1Department of Neurosurgery, Temple University Hospital, Philadelphia, Pennsylvania 19140, USA. Narayan@nimbus.temple.edu
Journal of Neurotrauma
|June 4, 2002
Summary
Traumatic brain injury (TBI) is a significant public health issue with limited effective treatments. A National Institute of Neurological Disorders and Stroke (NINDS) workshop identified key lessons to improve future clinical trial design and outcomes for TBI.
Area of Science:
- Neuroscience
- Public Health
- Clinical Trials
Background:
- Traumatic brain injury (TBI) presents a major global public health challenge, with high incidence rates in the United States.
- A significant number of TBI cases result in long-term disabilities, yet effective therapeutic options remain scarce.
- Past clinical trials for TBI have frequently failed to show significant improvements, despite promising preclinical data.
Framework:
- Challenges in designing and conducting TBI clinical trials have hindered therapeutic development.
- Lack of shared insights from failed trials risks repeating past mistakes.
- A workshop sponsored by the National Institute of Neurological Disorders and Stroke (NINDS) convened experts to address these issues.
Implementation:
- The workshop brought together diverse expertise from clinical, research, and pharmaceutical fields.
- Discussions focused on analyzing past trial failures and identifying strategies for future research.
- Key insights were generated to inform the planning and design of upcoming TBI studies.
Implications:
- Lessons learned from the NINDS workshop aim to enhance the success rate of future TBI clinical trials.
- Improved trial design and planning are crucial for advancing TBI treatment strategies.
- Sharing knowledge and insights is vital for progress in TBI research and patient care.